Evidence map›Paper›PMID 39457484›Full record

ArticleBiomedicines2024

A Multi-Omics Prognostic Model Capturing Tumor Stemness and the Immune Microenvironment in Clear Cell Renal Cell Carcinoma.

Beibei Xiong, Wenqiang Liu, Ying Liu, Tong Chen, Anqi Lin, Jiaao Song, Le Qu, Peng Luo, Aimin Jiang, Linhui Wang

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Beibei XiongDepartment of Oncology, The First People's Hospital of Shuangliu District, Chengdu 610200, China.
Wenqiang LiuDepartment of Urology, Changhai Hospital, Navel Medical University (Second Military Medical University), Shanghai 200433, China.
Ying LiuDepartment of Urology, Changhai Hospital, Navel Medical University (Second Military Medical University), Shanghai 200433, China.
Tong ChenDepartment of Urology, Changhai Hospital, Navel Medical University (Second Military Medical University), Shanghai 200433, China.
Anqi LinDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Jiaao SongDepartment of Urology, Changhai Hospital, Navel Medical University (Second Military Medical University), Shanghai 200433, China.
Le QuDepartment of Urology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China.
Peng LuoDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Aimin JiangDepartment of Urology, Changhai Hospital, Navel Medical University (Second Military Medical University), Shanghai 200433, China.ORCID 0000-0002-9563-983X
Linhui WangDepartment of Urology, Changhai Hospital, Navel Medical University (Second Military Medical University), Shanghai 200433, China.ORCID 0000-0002-4056-0462

Funding

National Natural Science Foundation of China 82372883
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer stem-like cellsimmune microenvironmentsprognostic modelrenal cell carcinoma

Identifiers

PMID39457484
PMCPMC11504857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.